Singapore markets closed

  • Straits Times Index

    2,998.77
    +2.85 (+0.10%)
     

  • S&P 500

    3,798.91
    +30.66 (+0.81%)
     

  • Dow

    30,930.52
    +116.26 (+0.38%)
     

  • Nasdaq

    13,197.18
    +198.68 (+1.53%)
     

  • BTC-USD

    34,434.43
    -170.12 (-0.49%)
     

  • CMC Crypto 200

    677.66
    -37.53 (-5.25%)
     

  • FTSE 100

    6,708.20
    -4.75 (-0.07%)
     

  • Gold

    1,834.90
    -5.30 (-0.29%)
     

  • Crude Oil

    53.47
    +0.49 (+0.92%)
     

  • 10-Yr Bond

    1.0920
    0.0000 (0.00%)
     

  • Nikkei

    28,523.26
    -110.20 (-0.38%)
     

  • Hang Seng

    29,962.47
    +320.19 (+1.08%)
     

  • FTSE Bursa Malaysia

    1,601.54
    -0.34 (-0.02%)
     

  • Jakarta Composite Index

    6,429.76
    +107.90 (+1.71%)
     

  • PSE Index

    7,143.30
    -55.15 (-0.77%)
     

Doctor Who festive special: New trailer sees cast favourites return and Daleks revolt

Annabel Nugent
·2-min read
(BBC)
(BBC)

The BBC has finally released a trailer for the highly anticipated New Year’s Day special of Doctor Who.

Set to air on 1 January, the forthcoming episode – titled “Revolution of the Daleks” – promises an action-packed start to 2021.

The one-minute trailer – released yesterday (29 November) – introduces a slew of guest stars who will appear in the special. Both John Barrowman and Chris Noth will reprise their roles as Captain Jack Harkness and Jack Robertson respectively.

Dame Harriet Walker, who recently appeared as assassin Dasha in season three of Killing Eve, and Misfits’s Nathan Stewart-Jarrett are also set to appear in the highly anticipated new year's instalment.

The episode will pick up where season 12 concluded, with the Doctor (Jodie Whittaker) locked away in a high-security alien prison, leaving Ryan, Graham and Yaz (Tosin Cole, Bradley Walsh and Mandip Gill) to face the Daleks alone.

Some fans, however, have voiced their disappointment at the trailer with many Twitter users debating whether the episode’s storyline, which sees the government employing Daleks as defence drones, may be too similar to previous instalments.

One user wrote: “Another story where the humans think Daleks are good and use them for their own purposes and then they turn against them. Wasn’t that the plot of one of Eleven’s first episodes?”

Fans have also finally got a release date to look forward to, with BBC having previously only confirmed that the special would air “during the upcoming festive period”.

“Revolution of the Daleks” will air on BBC One on 1 January 2021.

You can find out everything you need to know about this year’s holiday episode here.

Latest stories

  • Global Counter Unmanned Aerial Vehicle Defense System Market to Grow by $ 580.12 Million During 2020-2024 | Increased Focus Toward Electronic Warfare to Boost Growth | Technavio

    The Counter Unmanned Aerial Vehicle Defense System Market will grow by USD 580.12 mn during 2020-2024

  • Back to the office: Meet some of the firms that have committed to new London HQs

    The Evening Standard spoke to some of the companies that have signed for new central London offices since the first lockdown started…

  • Trump Leaves White House For The Last Time As President

    The president departed by snubbing Joe Biden's inauguration and fleeing to Mar-a-Lago.

  • Coronavirus news – live: Pfizer vaccine likely to work against UK variant as deaths ‘will continue to rise’

    Follow the latest updates here

  • Papadakis, Cizeron to skip World Championships

    The French skating federation said the ice dance world champions will skip the March 22-28 event in Stockholm, Sweden to focus on preparing for the 2022 Beijing Winter Olympics. Papadakis and Cizeron, who both contracted the novel coronavirus and recovered last year, are four-times world champions. "We have never known such a long time without competition," Cizeron said in a statement.

  • Trump’s final falsehoods: How farewell speech was littered with misinformation

    Compulsive exaggerator uses last podium appearance to gloss over his failings

  • Mogo Introduces 1% Bitcoin Cashback Rewards

    Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company empowering the next generation of consumers, today announced that their first-of-its-kind bitcoin rewards program has been extended to include the Mogo Visa* Platinum Prepaid Card ("MogoCard") and digital spending account. Beginning this month, members will earn 1% bitcoin cashback rewards for every purchase made on their MogoCard. Their rewards will be deposited monthly in cash directly into their bitcoin and rewards account.

  • Community Trust Bancorp, Inc. Reports Earnings for the Fourth Quarter and Year 2020

    Community Trust Bancorp, Inc. (NASDAQ: CTBI)

  • Disney Joins AT&T in the War on Theaters

    After a rough 2020 for movie theater companies, there might actually be one theater stock that could benefit from the pandemic.

  • Worldwide Emulsion Pressure Sensitive Adhesives Industry to 2025 - China to Dominate the Asia-Pacific Region - ResearchAndMarkets.com

    The "Emulsion Pressure Sensitive Adhesives Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

  • China revives conspiracy theory of US army link to Covid

    China revives conspiracy theory of US army link to CovidSuspicions about army lab spread on social media after official’s tit-for-tat response to US claim * Coronavirus – latest updates * See all our coronavirus coverage

  • Outlook on the Insulin Delivery System Global Market to 2025 - Cumulative Impact of COVID-19

    Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Insulin Delivery System Market Research Report by Product Type (Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Syringes), by End User (Hospitals, Retail channels, and Specialty Diabetic Clinics) - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Delivery System Market including Animas Corporation (Johnson and Johnson), Becton, Dickinson and Company, Biocon Limited, Eli Lilly and Company, Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., and Ypsomed Holding AG.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Delivery System Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth. Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Insulin Delivery System Market is expected to grow from USD 13,389.33 Million in 2020 to USD 18,646.20 Million by the end of 2025.2. The Global Insulin Delivery System Market is expected to grow from EUR 11,740.02 Million in 2020 to EUR 16,349.34 Million by the end of 2025.3. The Global Insulin Delivery System Market is expected to grow from GBP 10,436.90 Million in 2020 to GBP 14,534.60 Million by the end of 2025.4. The Global Insulin Delivery System Market is expected to grow from JPY 1,428,981.23 Million in 2020 to JPY 1,990,022.54 Million by the end of 2025.5. The Global Insulin Delivery System Market is expected to grow from AUD 19,443.09 Million in 2020 to AUD 27,076.76 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Insulin Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Product Type, the Insulin Delivery System Market is examined across Insulin Jet Injectors, Insulin Pens, Insulin Pumps, and Syringes.Based on End User, the Insulin Delivery System Market is examined across Hospitals, Retail channels, and Specialty Diabetic Clinics.Based on Geography, the Insulin Delivery System Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Insulin Delivery System Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Delivery System Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Delivery System Market?4. What is the competitive strategic window for opportunities in the Global Insulin Delivery System Market?5. What are the technology trends and regulatory frameworks in the Global Insulin Delivery System Market?6. What are the modes and strategic moves considered suitable for entering the Global Insulin Delivery System Market? Key Topics Covered: 1. Preface1.1. Objectives of the Study1.2. Market Segmentation & Coverage1.3. Years Considered for the Study1.4. Currency & Pricing1.5. Language1.6. Limitations1.7. Stakeholders2. Research Methodology2.1. Research Process2.1.1. Define: Research Objective2.1.2. Determine: Research Design2.1.3. Prepare: Research Instrument2.1.4. Collect: Data Source2.1.5. Analyze: Data Interpretation2.1.6. Formulate: Data Verification2.1.7. Publish: Research Report2.1.8. Repeat: Report Update2.2. Research Execution2.2.1. Initiation: Research Process2.2.2. Planning: Develop Research Plan2.2.3. Execution: Conduct Research2.2.4. Verification: Finding & Analysis2.2.5. Publication: Research Report2.3. Research Outcome3. Executive Summary3.1. Introduction3.2. Market Outlook3.3. Product Type Outlook3.4. End User Outlook3.5. Geography Outlook3.6. Competitor Outlook4. Market Overview4.1. Introduction4.2. Cumulative Impact of COVID-194.3. Geographic Growth Opportunities5. Market Insights5.1. Market Dynamics5.1.1. Drivers5.1.2. Restraints5.1.3. Opportunities5.1.4. Challenges5.2. Porters Five Forces Analysis5.2.1. Threat of New Entrants5.2.2. Threat of Substitutes5.2.3. Bargaining Power of Customers5.2.4. Bargaining Power of Suppliers5.2.5. Industry Rivalry6. Global Insulin Delivery System Market, By Product Type6.1. Introduction6.2. Insulin Jet Injectors6.3. Insulin Pens6.4. Insulin Pumps6.5. Syringes7. Global Insulin Delivery System Market, By End User7.1. Introduction7.2. Hospitals7.3. Retail channels7.4. Specialty Diabetic Clinics8. Americas Insulin Delivery System Market8.1. Introduction8.2. Argentina8.3. Brazil8.4. Canada8.5. Mexico8.6. United States9. Asia-Pacific Insulin Delivery System Market9.1. Introduction9.2. Australia9.3. China9.4. India9.5. Indonesia9.6. Japan9.7. Malaysia9.8. Philippines9.9. South Korea9.10. Thailand10. Europe, Middle East & Africa Insulin Delivery System Market10.1. Introduction10.2. France10.3. Germany10.4. Italy10.5. Netherlands10.6. Qatar10.7. Russia10.8. Saudi Arabia10.9. South Africa10.10. Spain10.11. United Arab Emirates10.12. United Kingdom11. Competitive Landscape11.1. FPNV Positioning Matrix11.1.1. Quadrants11.1.2. Business Strategy11.1.3. Product Satisfaction11.2. Market Ranking Analysis11.3. Market Share Analysis11.4. Competitive Scenario11.4.1. Merger & Acquisition11.4.2. Agreement, Collaboration, & Partnership11.4.3. New Product Launch & Enhancement11.4.4. Investment & Funding11.4.5. Award, Recognition, & Expansion12. Company Usability Profiles12.1. Animas Corporation (Johnson and Johnson)12.2. Becton, Dickinson and Company12.3. Biocon Limited12.4. Eli Lilly and Company12.5. Insulet Corporation12.6. Medtronic PLC12.7. Novo Nordisk A/S12.8. Sanofi12.9. Tandem Diabetes Care, Inc.12.10. Ypsomed Holding AG13. Appendix13.1. Discussion Guide For more information about this report visit https://www.researchandmarkets.com/r/v9cn8n CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Boris Johnson refuses to back Trump and Biden teams in calling Uighur situation ‘genocide’

    PM says China’s treatment of Muslim majority ‘utterly abhorrent’

  • Quorum Announces Board and Senior Leadership Changes

    CALGARY, Alberta, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX Venture: QIS) ("Quorum" or the "Corporation") announces changes to the Board of Directors and its senior leadership team as part of its One Quorum strategy. The Board of Directors of Quorum has appointed Neil McDonnell as its new Chair, succeeding Scot Eisenfelder, who resigned due to other business commitments. Mr. Eisenfelder will continue as a director of the company and the Corporation is delighted that he is remaining with the Board. In 2020, Quorum introduced its One Quorum strategy, which included moving to a functional business model from the divisional business structure created through the acquisitions of Autovance, DealerMine and Oasis. One of Quorum’s key value propositions to its dealership customers is the deep integration and single enterprise reporting functionality across its product suite and the following senior leadership appointments will capitalize on this integrated strategy: Mark Bennett - Vice President, Sales and Marketing. Under Mr. Bennett’s leadership, Quorum’s Sales and Marketing team will capitalize on cross selling opportunities across its existing customer base and driving acquisition of new dealers.Dan Ichelson - Senior Vice President, Development. Mr. Ichelson will drive an integrated development team to develop a seamlessly integrated product suite that delivers high Return on Investment (ROI) to dealers. Rick Johnston - Vice President, Product Management: Mr. Johnston to lead our product vision for the dealership’s vehicle sales department and to manage manufacturer and partner relationships.Jane Webb - Vice President, Product Management: Ms. Webb to lead our product vision for the dealership’s service department and to manage manufacturer and partner relationships. “We have structured our leadership team to accelerate Quorum’s vision of an integrated digital retailing strategy enabling dealership customers to both buy a car online and complete a touchless, transparent service experience. Along with Marilyn Bown, our Chief Financial Officer, and Mike Herenberg, our Chief Operating Officer, these changes round out Quorum’s senior management team,” stated Maury Marks, President & CEO. “I look forward to continuing to work with the Senior Leadership Team to advance Quorum’s presence and growth in the automotive marketplace under an integrated One Quorum strategy.” Mark Allen, Senior Vice President Business Development, is no longer with Quorum. “I would like to sincerely thank Mark for his contributions to Quorum over his 15 years with the company and wish him well as he moves to the next stage of his career,” added Mr. Marks. About Quorum Information Technologies Inc. Quorum is a North American company focused on developing, marketing, implementing and supporting its portfolio of software and services for automotive dealerships that includes: XSellerator, a Dealership Management System (DMS) that automates, integrates and streamlines key processes across departments in a dealership, and emphasizes revenue generation and customer satisfaction.DealerMine CRM, a sales and service Customer Relationship Management (CRM) system and set of Business Development Centre services that drives revenue into the critical sales and service departments in a dealership.Autovance, a modern retailing platform that helps dealerships attract more business through Digital Retailing (DR), improve in-store profits and closing rates through its desking tool and maximize their efficiency and CSI through Autovance’s F&I menu solutions fee.Advantage, a full showroom system for both franchised and independent dealerships and a comprehensive management system that includes accounting for the independent market. Quorum Information Technologies Inc. is traded on the Toronto Venture Exchange (TSX-V) under the symbol QIS. For additional information please go to www.QuorumInformationSystems.com. Forward-Looking InformationThis press release may contain certain forward-looking statements and forward-looking information ("forward-looking information") within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "expect", "may", "will", "project", "should" or similar words suggesting future outcomes. Quorum believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Forward-looking information is not a guarantee of future performance and involves a number of risks and uncertainties some of which are described herein. Such forward-looking information necessarily involves known and unknown risks and uncertainties, which may cause Quorum's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking information. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed this release and neither accepts responsibility for the adequacy or accuracy of this release. Contact: Maury Marks 403-777-0036Investors@QuorumInfoTech.com PDF available: http://ml.globenewswire.com/Resource/Download/b56f1782-877b-4ef3-bf01-b9dfb42a9e2e

  • Novak Djokovic hits back after criticism over Australian Open quarantine demands

    Novak Djokovic has issued a detailed and staunch defence of his requests to Australian Open organisers after being heavily criticised for his attempts to ease hard quarantine restrictions for players. Earlier this week, the men’s world no1 was labelled a “tool” by Australia’s Nick Kyrgios after reports that he had contacted tournament director Craig Tiley with a list of “demands” including reducing the period of quarantine and moving as many players as possible to private houses with tennis courts to enable them to train as well as permission for coaches and trainers to visit their players, and be housed on the same floor of their hotel. Premier of Victoria Dan Andrews subsequently made it publicly clear that there would be no changes or special treatment for the more than 70 tennis players in the midst of a 14-day lockdown ahead of the Australian Open that followed positive Covid-19 tests being recorded on their respective flights into Melbourne.

  • Trent Alexander-Arnold is a Theragun ambassador, but is the massager any good? Here’s our review

    We ask if you should invest in the footballer-favoured at-home massage tool for post-workout aches

  • Trump revokes ethics ban on aides as he exits Washington

    Outgoing U.S. President Donald Trump, who won the White House in part by promising to "drain the swamp" of Washington political maneuvering, on Wednesday revoked his executive order barring aides and other administration officials from lobbying. The restrictions, imposed soon after he took office in 2017, had targeted the kind of insider culture the Republican Trump had campaigned against and blocked the kind of lucrative gigs that he had said makes politicians beholden to business interests instead of everyday Americans. In an executive order released overnight, hours before he was due to leave office, Trump withdrew the ethics order that had said his appointees would not lobby their own agency for five years after leaving, and would not lobby any government appointee for two years.

  • What Disney Food Was Popular The Year You Were Born

    The House of the Mouse doesn't disappoint. From Redbook

  • Inauguration Day 2021 – live: Top Republicans to join Bidens in church and snub Trump farewell

    Live news and updates

  • Call My Agent!, season 4, review: A delicious au revoir from this subtle, snarky and very funny French dramedy

    The absence of writer Fanny Herrero costs the final season a scintilla of charm but guest appearances from Sigourney Weaver, Jean Reno and Charlotte Gainsbourg add glamour